Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Uma Athale

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Journal of Pediatric Hematology/Oncology|June 15, 2018
Health Status and Health-related Quality of Life Measurement in Pediatric Cancer Clinical Trials: An Examination of the DFCI 00-01 Acute Lymphoblastic Leukemia ProtocolCharlene Rae, William Furlong, David Feeny, et al.
European Journal of Cancer (Oxford, England : 1990)|May 12, 2021
Health care utilisation and costs associated with different treatment protocols for newly diagnosed childhood acute lymphoblastic leukaemia: A population-based study in Ontario, CanadaSumit Gupta, Rinku Sutradhar, Qing Li, et al.
Pediatric Blood & Cancer|May 18, 2021
Phase-specific risks of outpatient visits, emergency visits, and hospitalizations during Children's Oncology Group-based treatment for childhood acute lymphoblastic leukemia: A population-based studyMylene Bassal, Mariana Silva, Serina Patel, et al.
Pediatric Blood & Cancer|July 23, 2019
Management of chronic myeloid leukemia in children and adolescents: Recommendations from the Children's Oncology Group CML Working GroupUma Athale, Nobuko Hijiya, Briana C Patterson, et al.
Pediatric Blood & Cancer|August 29, 2025
Introductory Course in Pediatric Oncology for Registrars/Residents and Medical Officers in Sub-Saharan Africa: A Pilot StudySaman K Hashmi, Inam Chitsike, Justin Makasa Mulindwa, et al.
Archives of Disease in Childhood. Fetal and Neonatal Edition|July 4, 2020
Outcomes of haemoglobin Bart's hydrops fetalis following intrauterine transfusion in Ontario, CanadaHui Jue Zhang, Ali Amid, Laura A Janzen, et al.
BMJ Open|September 13, 2019
Evaluating the endometabolic and bone health effects of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukaemia: a systematic review protocolJanatani Balakumaran, Tanisha Birk, Breanne Golemiec, et al.
Frontiers in Medicine|May 19, 2025
Sickle hemoglobinopathy research in Zimbabwe and Zambia: setting up an international sickle cell disease registryPatience Kuona, Gwendoline Q Kandawasvika, Catherine Chunda-Liyoka, et al.
British Journal of Haematology|January 25, 2020
Experience with ponatinib in paediatric patients with leukaemiaJenna Rossoff, Van Huynh, Rachel E Rau, et al.
Transfusion Medicine (Oxford, England)|May 21, 2020
Utilising red cell antigen genotyping and serological phenotyping in sickle cell disease patients to risk-stratify patients for alloimmunisation riskAndrew W Shih, Matthew T S Yan, Allahna L Elahie, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Journal of Pediatric Hematology/Oncology|June 15, 2018
Health Status and Health-related Quality of Life Measurement in Pediatric Cancer Clinical Trials: An Examination of the DFCI 00-01 Acute Lymphoblastic Leukemia ProtocolCharlene Rae, William Furlong, David Feeny, et al.
European Journal of Cancer (Oxford, England : 1990)|May 12, 2021
Health care utilisation and costs associated with different treatment protocols for newly diagnosed childhood acute lymphoblastic leukaemia: A population-based study in Ontario, CanadaSumit Gupta, Rinku Sutradhar, Qing Li, et al.
Pediatric Blood & Cancer|May 18, 2021
Phase-specific risks of outpatient visits, emergency visits, and hospitalizations during Children's Oncology Group-based treatment for childhood acute lymphoblastic leukemia: A population-based studyMylene Bassal, Mariana Silva, Serina Patel, et al.
Pediatric Blood & Cancer|July 23, 2019
Management of chronic myeloid leukemia in children and adolescents: Recommendations from the Children's Oncology Group CML Working GroupUma Athale, Nobuko Hijiya, Briana C Patterson, et al.
Pediatric Blood & Cancer|August 29, 2025
Introductory Course in Pediatric Oncology for Registrars/Residents and Medical Officers in Sub-Saharan Africa: A Pilot StudySaman K Hashmi, Inam Chitsike, Justin Makasa Mulindwa, et al.
Archives of Disease in Childhood. Fetal and Neonatal Edition|July 4, 2020
Outcomes of haemoglobin Bart's hydrops fetalis following intrauterine transfusion in Ontario, CanadaHui Jue Zhang, Ali Amid, Laura A Janzen, et al.
BMJ Open|September 13, 2019
Evaluating the endometabolic and bone health effects of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukaemia: a systematic review protocolJanatani Balakumaran, Tanisha Birk, Breanne Golemiec, et al.
Frontiers in Medicine|May 19, 2025
Sickle hemoglobinopathy research in Zimbabwe and Zambia: setting up an international sickle cell disease registryPatience Kuona, Gwendoline Q Kandawasvika, Catherine Chunda-Liyoka, et al.
British Journal of Haematology|January 25, 2020
Experience with ponatinib in paediatric patients with leukaemiaJenna Rossoff, Van Huynh, Rachel E Rau, et al.
Transfusion Medicine (Oxford, England)|May 21, 2020
Utilising red cell antigen genotyping and serological phenotyping in sickle cell disease patients to risk-stratify patients for alloimmunisation riskAndrew W Shih, Matthew T S Yan, Allahna L Elahie, et al.
Pageof 5